Daveen Chopra - Dec 15, 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, TMTT
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Dec 15, 2023
Transactions value $
-$132,927
Form type
4
Date filed
12/15/2023, 05:22 PM
Previous filing
Dec 6, 2023
Next filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $415K +7K +29.23% $59.26 31K Dec 15, 2023 Direct
transaction EW Common Stock Sale -$548K -7K -22.62% $78.25 24K Dec 15, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -7K -50% $0.00 7K Dec 15, 2023 Common Stock 7K $59.26 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $78.24 to $78.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.